Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP‐1 and NFκB transcription factors

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Neurochemistry

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.2007.04633.xPMID 17596214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adenovirus-mediated expression of a dominant negative Ku70 fragment radiosensitizes human tumor cells under aerobic and hypoxic conditions.

  2007cited by this paper
• Modulation of iNOS expression by a nitric oxide-releasing derivative of the natural antioxidant ferulic acid in activated RAW 264.7 macrophages.

  2006cited by this paper
• Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells.

  2006cited by this paper
• Curcumin-induced Histone Hypoacetylation Enhances Caspase-3-dependent Glioma Cell Death and Neurogenesis of Neural Progenitor Cells

  2006cited by this paper
• Silencing of the human microsomal glucose‐6‐phosphate translocase induces glioma cell death: Potential new anticancer target for curcumin

  2006cited by this paper
• Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells.

  2006cited by this paper
• Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells.

  2005cited by this paper
• Cell Death Independent of Caspases: A Review

  2005cited by this paper
• Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells.

  2005cited by this paper
• Inhibition of Cellular Proliferation and Induction of Apoptosis by Curcumin in Human Malignant Astrocytoma Cell Lines

  2005cited by this paper
• Theoretical prediction of the relationship between phenol function and COX-2/AP-1 inhibition for ferulic acid-related compounds.

  2005cited by this paper
• Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria.

  2005cited by this paper
• Astrocyte-Derived Transforming Growth Factor-β Mediates the Neuroprotective Effects of 17β-Estradiol: Involvement of Nonclassical Genomic Signaling Pathways

  2005cited by this paper
• Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy.

  2005influential reference
• Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFκB

  2005cited by this paper
• Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways.

  2005cited by this paper
• Autophagy as a cell death and tumor suppressor mechanism

  2004cited by this paper
• Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats.

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Multiple cell death pathways as regulators of tumour initiation and progression

  2004cited by this paper
• Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress.

  2004cited by this paper
• Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications.

  2004cited by this paper
• Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder.

  2004cited by this paper
• Down‐regulation of Bcl‐2 and Bcl‐xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death

  2003cited by this paper
• NF-kappaB in cancer: a marked target.

  2003influential reference
• Enhancement of platinum-induced cytotoxicity by O6-benzylguanine.

  2003cited by this paper
• NF-κB in cancer: a marked target

  2003influential reference
• Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth.

  2003cited by this paper
• 4-Hydroxy-3-methoxybenzoic acid methyl ester: a curcumin derivative targets Akt/NF kappa B cell survival signaling pathway: potential for prostate cancer management.

  2003cited by this paper
• The Activation of c-Jun NH2-terminal Kinase (JNK) by DNA-damaging Agents Serves to Promote Drug Resistance via Activating Transcription Factor 2 (ATF2)-dependent Enhanced DNA Repair*

  2003cited by this paper
• Potentiation of Chemotherapeutic Agents following Antagonism of Nuclear Factor kappa B in Human Gliomas

  2003cited by this paper
• Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors.

  2003influential reference
• Targeted Molecular Therapy of GBM

  2003cited by this paper
• Astrocyte Protection of Neurons

  2003cited by this paper
• Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo.

  2003cited by this paper
• Neuroprotective effects of estrogen and tamoxifen in vitro

  2003cited by this paper
• O6‐Methylguanine‐DNA Methyltransferase (MGMT) as a Determinant of Resistance to Camptothecin Derivatives

  2002cited by this paper
• An antisense oligonucleotide targeted to human Ku86 messenger RNA sensitizes M059K malignant glioma cells to ionizing radiation, bleomycin, and etoposide but not DNA cross-linking agents.

  2002cited by this paper
• Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance

  2002cited by this paper
• Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.

  2002cited by this paper
• The molecular mechanisms for the antitumorigenic effect of curcumin.

  2002cited by this paper
• Elevated JNK activation contributes to the pathogenesis of human brain tumors

  2002cited by this paper
• Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: Upregulation of calpain and caspase‐3

  2002cited by this paper
• Triggering caspase-independent cell death to combat cancer.

  2002cited by this paper
• Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma.

  2002cited by this paper
• Death and anti-death: tumour resistance to apoptosis

  2002cited by this paper
• Cell cycle regulation of NF-kappa b-binding activity in cells from human glioblastomas.

  2001cited by this paper
• The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

  2001cited by this paper
• Cell cycle regulation of NF-κB-binding activity in cells from human glioblastomas

  2001cited by this paper
• Four deaths and a funeral: from caspases to alternative mechanisms

  2001cited by this paper
• Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

  2001cited by this paper
• Protective Role for c-Jun in the Cellular Response to DNA Damage*

  2001cited by this paper
• Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo

  2000cited by this paper
• Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-κB inhibition

  2000cited by this paper
• Inhibition of c-Jun N-Terminal Kinase 2 Expression Suppresses Growth and Induces Apoptosis of Human Tumor Cells in a p53-Dependent Manner

  2000cited by this paper
• Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents

  2000cited by this paper
• c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma Cells*

  2000cited by this paper
• Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1

  2000cited by this paper
• Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells.

  1999cited by this paper
• Inhibition of the Jun kinase pathway blocks DNA repair, enhances p53-mediated apoptosis and promotes gene amplification.

  1999cited by this paper
• Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.

  1999cited by this paper
• Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB

  1999cited by this paper
• RESPONSE: re: brain and other central nervous system cancers: recent trends in incidence and mortality

  1999cited by this paper
• Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells

  1999influential reference
• NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis

  1999cited by this paper
• Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcumin.

  1999cited by this paper
• NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

  1998cited by this paper
• Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.

  1998cited by this paper
• The Jun Kinase/Stress-activated Protein Kinase Pathway Functions to Regulate DNA Repair and Inhibition of the Pathway Sensitizes Tumor Cells to Cisplatin*

  1997influential reference
• Understanding and manipulating O6-methylguanine-DNA methyltransferase expression.

  1997cited by this paper
• Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

  1996cited by this paper
• Human brain tumor O6‐methylguanine‐DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy

  1996cited by this paper
• Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation.

  1995cited by this paper
• Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas

  1995cited by this paper
• Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line

  1995cited by this paper
• p53 status and the efficacy of cancer therapy in vivo.

  1994cited by this paper
• Apoptosis in cancer therapy: crossing the threshold.

  1994cited by this paper
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

  1993cited by this paper
• Clonal expansion of p53 mutant cells is associated with brain tumour progression

  1992cited by this paper
• Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.

  1990cited by this paper
• The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat.

  1978cited by this paper
• INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY

  1976cited by this paper

• Redundancy in Growth Factor Receptor Signaling in Adult Astrocytoma Resistance to Small-Molecule Tyrosine Kinase Inhibitors

  2026cites this paper
• Engineered extracellular vesicles for nose-to-brain co-delivery of chlorotoxin and curcumin for treatment of glioblastoma.

  2025cites this paper
• A novel approach to glioblastoma multiforme treatment using modulation of key pathways by naturally occurring small molecules

  2025cites this paper
• Folic Acid-Decorated Lipidic Nanocapsules Co-Loaded with Atorvastatin and Curcumin to Enhance Glioma Targeting in Mice

  2025cites this paper
• Anti-tumor Effects of Curcumin and ABT-737 in Combination Therapy for Glioblastoma in Vivo

  2025cites this paper
• Potential Therapeutic Appliances of Dietary Polyphenols: Resveratrol and Curcumin in Treatment of Gliomas

  2025cites this paper
• The Pivotal Role of NF-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications

  2025cites this paper
• Molecular Insights into HPV-Driven Cervical Cancer: Oncoproteins, Immune Evasion, and Epigenetic Modifications

  2025cites this paper
• Curcumin for the treatment of pituitary adenomas: the potential of a single agent for multifaceted therapeutic effects

  2025cites this paper
• Transcriptomic-Driven Drug Repurposing Reveals SP600125 as a Promising Drug Candidate for the Treatment of Glial-Mesenchymal Transition in Glioblastoma

  2025cites this paper
• Progress of anti-tumor research on natural products combined with doxorubicin.

  2025cites this paper
• Curcumin-Induced Molecular Mechanisms in U-87 MG Glioblastoma Cells: Insights from Global Gene Expression Profiling

  2025cites this paper
• Glioblastoma Therapy: Past, Present and Future

  2024cites this paper
• Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance

  2024cites this paper
• The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells

  2024cites this paper
• Action of Curcumin on Glioblastoma Growth: A Systematic Review with Meta-Analysis of Animal Model Studies

  2024cites this paper
• Enhancing the therapeutic potential of curcumin: a novel nanoformulation for targeted anticancer therapy to colorectal cancer with reduced miR20a and miR21 expression

  2024cites this paper
• Molecular, biochemical and histological assessment in paraquat induced neurotoxicity: restoring role of nano-curcumin in an experimental study.

  2024cites this paper
• Phytocompounds and Nanoformulations for Anticancer Therapy: A Review

  2024cites this paper
• Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms

  2024cites this paper
• Biomacromolecules as Immunomodulators: Utilizing Nature’s Tools for Immune Regulation

  2024cites this paper
• The effect of curcumin in combination with radiation therapy and hyperthermia for a glioblastoma spheroid model

  2024cites this paper
• Synergistic Anti-Cancer Effects of Isocnicin and Radiotherapy in Glioblastoma: A Natural Compound’s Potential

  2024cites this paper
• The Dynamic Role of Curcumin in Mitigating Human Illnesses: Recent Advances in Therapeutic Applications

  2024cites this paper
• Curcumin-based nanomedicines: A promising avenue for brain neoplasm therapy

  2023cites this paper
• Mechanism insights of curcumin and its analogues in cancer: An update

  2023influential citation
• An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments

  2023cites this paper
• Effects of curcumin nanodelivery on schizophrenia and glioblastoma.

  2023cites this paper
• A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma.

  2023cites this paper
• Improving the targeted delivery of curcumin to esophageal cancer cells via a novel formulation of biodegradable lecithin/chitosan nanoparticles with downregulated miR-20a and miR-21 expression

  2023cites this paper
• Active Ingredients from Chinese Medicine for Combination Cancer Therapy

  2023cites this paper
• A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ

  2023cites this paper
• Antioxidant curcumin induces oxidative stress to kill tumor cells (Review)

  2023cites this paper
• Natural products as chemo-radiation therapy sensitizers in cancers.

  2022cites this paper
• Mechanistic Role of HPV-Associated Early Proteins in Cervical Cancer: Molecular Pathways and Targeted Therapeutic Strategies.

  2022cites this paper
• Multifunctional PEGylated Niosomal Nanoparticle-Loaded Herbal Drugs as a Novel Nano-Radiosensitizer and Stimuli-Sensitive Nanocarrier for Synergistic Cancer Therapy

  2022cites this paper
• Antioxidants in brain tumors: current therapeutic significance and future prospects

  2022cites this paper
• Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study

  2022cites this paper
• Ameliorating potential of curcumin and its analogue in central nervous system disorders and related conditions: A review of molecular pathways

  2022cites this paper
• Natural Plant Compounds: Does Caffeine, Dipotassium Glycyrrhizinate, Curcumin, and Euphol Play Roles as Antitumoral Compounds in Glioblastoma Cell Lines?

  2022cites this paper
• Curcumin in Combination with Other Adjunct Therapies for Brain Tumor Treatment: Existing Knowledge and Blueprint for Future Research

  2022influential citation
• Review on the Therapeutic Potential of Curcumin and its Derivatives on Glioma Biology

  2022cites this paper
• Therapeutic effect of natural polyphenols against glioblastoma

  2022influential citation
• Cancer treatment: from traditional Chinese herbal medicine to the liposome delivery system

  2022cites this paper
• Natural Products Targeting Hsp90 for a Concurrent Strategy in Glioblastoma and Neurodegeneration

  2022cites this paper
• Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers

  2022cites this paper
• Cross-platform analysis reveals cellular and molecular landscape of glioblastoma invasion.

  2022cites this paper
• Radiosensitizing Effect of Curcumin on Human Bladder Cancer Cell Lines: Impact on DNA Repair Mechanisms

  2021cites this paper
• Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases

  2021influential citation
• Immunomodulatory phytochemicals for chemoprevention

  2021cites this paper
• Anti-glioblastoma effects of nanomicelle-curcumin plus erlotinib.

  2021cites this paper
• Nutraceuticals in brain health

  2021cites this paper
• A State of the Art of Antioxidant Properties of Curcuminoids in Neurodegenerative Diseases

  2021cites this paper
• Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy

  2021cites this paper
• Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects

  2021cites this paper
• Curcumin Inhibits Viability of Clear Cell Renal Cell Carcinoma by Down-Regulating ADAMTS18 Gene Methylation though NF-κ B and AKT Signaling Pathway

  2021cites this paper
• HPV-mediated Cervical Cancer: A Systematic review on Immunological Basis, Molecular Biology and Immune evasion mechanisms.

  2021cites this paper
• Inhibiting IL-6 During Cytokine Storm in COVID-19: Potential Role of Natural Products

  2021cites this paper
• Human Papillomavirus and Cellular Pathways: Hits and Targets

  2021cites this paper
• The protective effects of curcumin in cerebral ischemia and reperfusion injury through PKC-θ signaling

  2021cites this paper
• Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro

  2021cites this paper
• Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma

  2021cites this paper
• Systematic analysis of potential targets of the curcumin analog pentagamavunon-1 (PGV-1) in overcoming resistance of glioblastoma cells to bevacizumab

  2021cites this paper
• Potential implications of hydrogen peroxide in the pathogenesis and therapeutic strategies of gliomas

  2020cites this paper
• Natural products as promising targets in glioblastoma multiforme: a focus on NF-κB signaling pathway

  2020cites this paper
• Therapeutic potentials of curcumin in the treatment of glioblstoma.

  2020cites this paper
• Plant-Based Drugs as an Adjuvant to Cancer Chemotherapy

  2020cites this paper
• Plant Polyphenolic Compounds Potentiates Therapeutic Efficiency of Anticancer Chemotherapeutic Drugs: A Review.

  2020cites this paper
• Radiosensitizing Potential of Curcumin in Different Cancer Models

  2020cites this paper
• Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer.

  2020cites this paper
• Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity

  2020cites this paper
• Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression

  2020cites this paper
• Curcumin induces apoptosis in lung cancer cells by 14-3-3 protein-mediated activation of Bad

  2020cites this paper
• Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders

  2020cites this paper
• Curcumin potentiates laryngeal squamous carcinoma radiosensitivity via NF-ΚB inhibition by suppressing IKKγ expression

  2020cites this paper
• The role of curcumin/curcuminoids during gastric cancer chemotherapy: A systematic review of non-clinical study.

  2020cites this paper
• Design of new improved curcumin derivatives to multi-targets of cancer and inflammation.

  2020cites this paper
• The Multi-Faceted Effect of Curcumin in Glioblastoma from Rescuing Cell Clearance to Autophagy-Independent Effects

  2020cites this paper
• Natural Compounds Extracted from Medicinal Plants and Their Immunomodulatory Activities

  2020cites this paper
• Experimental and clinical studies on radiation and curcumin in human glioma

  2020cites this paper
• Effects of curcumin on neurological diseases: focus on astrocytes

  2020cites this paper
• Opportunities for Health Promotion: Highlighting Herbs and Spices to Improve Immune Support and Well-being.

  2020cites this paper
• NF-кB inhibition by DHMEQ: in vitro antiproliferative effects on pilocytic astrocytoma and concise review of the current literature

  2020cites this paper
• Curcumin Loaded in Niosomal Nanoparticles Improved the Anti-tumor Effects of Free Curcumin on Glioblastoma Stem-like Cells: an In Vitro Study

  2020cites this paper
• Can Other Herbal Drugs Affect Signaling Pathways in Glioblastoma Cells Similar to Curcumin

  2020cites this paper
• Curcumin circumvent Lactate-induced Chemoresistance in Hepatic cancer cells through modulation of Hydroxycarboxylic acid receptor-1.

  2020cites this paper
• pH-responsive hyaluronic acid-based nanoparticles for targeted curcumin delivery and enhanced cancer therapy.

  2020cites this paper
• The therapeutic potential of curcumin for the treatment of glioblastoma multiforme

  2020cites this paper
• Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer

  2019cites this paper
• Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-κB Signaling Pathway

  2019cites this paper
• Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme.

  2019cites this paper
• Curcumin and Inflammatory Brain Diseases

  2019cites this paper
• Anti-Migration and Anti-Invasion Effects of Curcumin via Suppression of Fascin Expression in Glioblastoma Cells

  2019cites this paper
• Combinations of the antioxidants sulforaphane or curcumin and the conventional antineoplastics cisplatin or doxorubicin as prospects for anticancer chemotherapy.

  2019cites this paper
• The genus Tragopogon (Asteraceae): A review of its traditional uses, phytochemistry, and pharmacological properties.

  2019cites this paper
• Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments

  2019cites this paper
• Curcumin and endometrial carcinoma: an old spice as a novel agent

  2019cites this paper
• In vitro Antineoplastic Activity of Dye Compounds on Human Glioblastoma Cells

  2019cites this paper
• Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF- κ B Signaling Pathway.

  2019cites this paper
• Investigation of cytotoxic, genotoxic, and apoptotic effects of curcumin on glioma cells.

  2019cites this paper